Skip to content
10-Q

Quarterly Report

Skye Bioscience, Inc. SKYE

0001628280-25-051031

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 32.06M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.67M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 38.82M sh
Shares Diluted Q3 2025 · Sep 30, 2024 35.32M sh
Capex Q3 2025 · Sep 30, 2025 $6.31K
Capex Q3 2025 · Sep 30, 2024 $1.55M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$33.3M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$17.06M
Short Term Investments Q3 2025 · Sep 30, 2025 $16.87M
Short Term Investments Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $18.44M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $68.42M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $67.41M
Stockholders Equity Q3 2025 · Sep 30, 2025 $32.84M
Stockholders Equity Q3 2025 · Jun 30, 2025 $43.68M
Stockholders Equity Q3 2025 · Mar 31, 2025 $59.25M
Stockholders Equity Q3 2025 · Dec 31, 2024 $68.15M
Stockholders Equity Q3 2025 · Sep 30, 2024 $75.8M
Stockholders Equity Q3 2025 · Jun 30, 2024 $72.81M
Stockholders Equity Q3 2025 · Mar 31, 2024 $78.88M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$2.13M
Current Liabilities Q3 2025 · Sep 30, 2025 $8.37M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.34M
Total Liabilities Q3 2025 · Sep 30, 2025 $8.49M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.61M
Current Assets Q3 2025 · Sep 30, 2025 $39.92M
Current Assets Q3 2025 · Dec 31, 2024 $70.83M
Total Assets Q3 2025 · Sep 30, 2025 $41.32M
Total Assets Q3 2025 · Dec 31, 2024 $72.76M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.32
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.05
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.32
Eps Basic Q3 2025 · Sep 30, 2025 −$1.05
Eps Basic Q3 2025 · Sep 30, 2024 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.48
Sga Expense Q3 2025 · Sep 30, 2025 $3.91M
Sga Expense Q3 2025 · Sep 30, 2025 $12.38M
Sga Expense Q3 2025 · Sep 30, 2024 $4.64M
Sga Expense Q3 2025 · Sep 30, 2024 $13.17M
Net Income Q3 2025 · Sep 30, 2025 −$12.75M
Net Income Q3 2025 · Sep 30, 2025 −$41.48M
Net Income Q3 2025 · Jun 30, 2025 −$17.62M
Net Income Q3 2025 · Mar 31, 2025 −$11.1M
Net Income Q3 2025 · Sep 30, 2024 −$3.9M
Net Income Q3 2025 · Sep 30, 2024 −$16.82M
Net Income Q3 2025 · Jun 30, 2024 −$7.9M
Net Income Q3 2025 · Mar 31, 2024 −$5.02M
Operating Income Q3 2025 · Sep 30, 2025 −$13.26M
Operating Income Q3 2025 · Sep 30, 2025 −$43.27M
Operating Income Q3 2025 · Sep 30, 2024 −$4.97M
Operating Income Q3 2025 · Sep 30, 2024 −$19.53M